EVALUATION OF THE EFFICACY AND SAFETY OF DIACEREIN IN PATIENTS WITH OSTEOARTHRITIS OF THE HIP JOINTS
Objective. To evaluate the efficacy, tolerability and safety of the drug Diacerein (Artrocker) in patients with osteoarthritis (OA) of the hip joints after continuous administration for 4 months and the duration of the drug effects for 2 months. Materials and methods. The study included 30 patients...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2017-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1666 |
| Summary: | Objective. To evaluate the efficacy, tolerability and safety of the drug Diacerein (Artrocker) in patients with osteoarthritis (OA) of the hip joints after continuous administration for 4 months and the duration of the drug effects for 2 months. Materials and methods. The study included 30 patients with significant (by ARA criteria) OA of the hip joints of Stage 2-3 according to Kellgren-Lawrence. The average age of patients was 63.6 ± 5.8 years. Patients took Artrocker for the first 2 weeks by 50 mg (1 capsule), and then by 100 per day (2 capsules). Evaluation of the therapy effectiveness was evaluated by the WOMAC index (pain, stiffness and functional impairment), dynamics of the index in % relative to the initial visit; the health questionnaire EQ-5D; the test «get up and go», assessment of the therapy effectiveness by physician and patient overall assessment of tolerability. Results. The decrease in the intensity of pain and stiffness on the WOMAC index were noted by the end of the first month of therapy and persisted for the whole observation period (245,6 ± 64,3 and 142.5 ± 67,3 and 97.8 ± 35.6 and 64,3 ± 30,1; p = 0,000 respectively). Significant improvement of the functional status of the joints was achieved at the end of the treatment period, which remained until the end of observation (854,6 ± 306,8 and 637,2 ± of 253.7, p = 0.000). The decrease in total WOMAC index was recorded at visit 3 (1182,6 ± 834,2 358,6 and ± 322,1 p = 0,000). Statistically significant improvement of the test «get up and go» assessment of general health and quality of life according to EQ-5D were observed from the third visit to the end of the observation. Evaluation of tolerance to treatment done by a patient and a doctor did not differ from each other: the excellent tolerability was noted for 27.5% of patients, good-65,5%, and satisfactory - for 7% of patients. Only one adverse event – nausea – was noted in the study, which was the reason for the discontinuation of the drug and withdrawl of the patient from the study. |
|---|---|
| ISSN: | 2079-701X 2658-5790 |